Prognostic implications of overt congestion in heart failure with preserved ejection fraction and the interaction with spironolactone: Insights from TOPCAT

• Yingwen Lin,
• Hengli Zhao,
• Dongtu Hu,
• Jia Huang,
• You Peng,
• Juncong Li,
• Dingli Xu,
• Qingchun Zeng,
• Ting Gao,
• Xiuyuan Hao

Affiliations

Yingwen Lin

1 State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Hengli Zhao

2 Guangdong Provincial Key Laboratory of Clinical Pharmacology, Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510515, China

Dongtu Hu

1 State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Jia Huang

3 Department of Radiology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, China

You Peng

4 Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.

Juncong Li

1 State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Dingli Xu

1 State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Qingchun Zeng

1 State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Ting Gao

Xiuyuan Hao